www.ftc.gov/enforcement/cases-proceedings/121-0028/abbvie-inc-et-al

Jul 2, 2018 ... Federal Trade Commission, Plaintiff, v. AbbVie Inc.; Abbott Laboratories; Unimed Pharmaceuticals, LLC; Besins Healthcare, Inc.; and Teva ...

www.law360.com/cases/546a34448d3fdf7ee4000001

Parties, docket activity and news coverage of federal case Mitchell et al v. AbbVie , Inc. et al, case number 1:14-cv-09178, from Illinois Northern Court.

www.law360.com/cases/54cac8811206c5177300000d

Parties, docket activity and news coverage of federal case Konrad et al v. AbbVie, Inc. et al, case number 1:15-cv-00966, from Illinois Northern Court.

www.gpo.gov/fdsys/pkg/USCOURTS-ilnd-1_14-cv-01748

Abbott Laboratories Incorporated, Defendant Abbott Laboratories ... Damon Aaron, Plaintiff Paul Aaron, Plaintiff ... Muhammed Al Dami, Plaintiff .... Damon Beasley, Plaintiff .... Robert V Blyzka, Plaintiff Darcy G ...... AbbVie Inc. et al., Case No.

www.leagle.com/decision/infdco20180315c35

Mar 14, 2018 ... This document relates to: Medical Mutual of Ohio, Plaintiff, v. AbbVie Inc., et al., Defendants. United States District Court, N.D. Illinois, Eastern ...

www.leagle.com/decision/infdco20151224628

Dec 22, 2015 ... Patricia Mashburn, et al. v. AbbVie Inc.; Abbott 1:15-cv-10770 * Dismiss Testopel claims Laboratories; AbbVie Products LLC; Unimed against ...

www.plainsite.org/judges/delaware-district-court/gregory-m-sleet

7/17/2017 · 1:17-cv-00971 · Frodyma v. Albany Molecular Research, Inc. et al ...... 12/31/2013 · 1:13-cv-02105 · Abbott Diabetes Care Inc. v. DexCom Inc.

www.vindy.com/news/2016/nov/16/courts

Nov 16, 2016 ... Leroy E. Braxton et al, money. Abbvie US LLC v. ... Mark Koenig v. Koniowsky Construction Inc. et al, notice of appeal. ... Pecchia et al v. Youngstown Skate Inc. et al, order of magistrate. .... Damon Irby Sr. v. Akesha Bowman ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5544150

Jul 7, 2017 ... Mantle cell lymphoma (MCL) comprises approximately 7% of all non-Hodgkin ... group were statistically superior to those of the early treatment group (NR versus 64 months, p = 0.004). ..... Millennium, Celgene, Gilead, Pharmacyclics, Teva, and Abbvie. Go to: .... Damon LE, Johnson JL, Niedzwiecki D, et al.